APPENDIX CARCINOMA
Clinical trials for APPENDIX CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new APPENDIX CARCINOMA trials appear
Sign up with your email to follow new studies for APPENDIX CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New algorithm aims to keep chemo on schedule for cancer patients
Disease control Recruiting nowThis study tests a tool called PAGODA that helps doctors adjust chemotherapy doses ahead of time to avoid unplanned treatment delays. About 420 people with cancers of the digestive system (like colon, stomach, or esophageal cancer) will take part. The goal is to see if using this…
Matched conditions: APPENDIX CARCINOMA
Phase: NA • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated May 17, 2026 03:54 UTC
-
New hope for rare gut cancers: drug combo shows promise in early trial
Disease control Recruiting nowThis study tests a combination of three drugs (surufatinib, sintilimab, and capecitabine) in people with advanced small bowel or appendix cancer that has spread and not responded to prior treatment. The goal is to see if this combination can shrink tumors or slow cancer growth. A…
Matched conditions: APPENDIX CARCINOMA
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
Cancer care at home: a game changer for patients?
Symptom relief Recruiting nowThis study compares giving cancer treatment at home versus in a clinic for people with advanced cancers. The goal is to see if home treatment reduces stress, financial burden, and improves the overall experience. About 220 participants will be randomly assigned to receive their t…
Matched conditions: APPENDIX CARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated May 14, 2026 12:04 UTC